Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022 at 05:58 pm EDT
Share
Jia Jie Biomedical Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 69.07 million compared to TWD 51.19 million a year ago. Net loss was TWD 1.45 million compared to TWD 0.408 million a year ago. Basic loss per share from continuing operations was TWD 0.02. Diluted loss per share from continuing operations was TWD 0.02. Basic loss per share was TWD 0.02. Diluted loss per share was TWD 0.02.
For the six months, sales was TWD 145.38 million compared to TWD 105.21 million a year ago. Net loss was TWD 3.5 million compared to TWD 3.42 million a year ago. Basic loss per share from continuing operations was TWD 0.04 compared to TWD 0.04 a year ago. Diluted loss per share from continuing operations was TWD 0.04 compared to TWD 0.04 a year ago. Basic loss per share was TWD 0.04 compared to TWD 0.04 a year ago. Diluted loss per share was TWD 0.04 compared to TWD 0.04 a year ago.
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.
JIA JIE BIOMEDICAL CO., LTD. 
